Cumberland Pharmaceuticals Inc
NASDAQ:CPIX

Watchlist Manager
Cumberland Pharmaceuticals Inc Logo
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Watchlist
Price: 2.39 USD 1.7% Market Closed
Market Cap: 35.8m USD

Intrinsic Value

The intrinsic value of one CPIX stock under the Base Case scenario is 1.77 USD. Compared to the current market price of 2.39 USD, Cumberland Pharmaceuticals Inc is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CPIX Intrinsic Value
1.77 USD
Overvaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cumberland Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CPIX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CPIX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cumberland Pharmaceuticals Inc.

Explain Valuation
Compare CPIX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CPIX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cumberland Pharmaceuticals Inc

Current Assets 29.9m
Cash & Short-Term Investments 15.2m
Receivables 10.4m
Other Current Assets 4.3m
Non-Current Assets 36m
PP&E 7.9m
Intangibles 15.9m
Other Non-Current Assets 12.2m
Current Liabilities 24.3m
Accounts Payable 13.8m
Accrued Liabilities 401.4k
Other Current Liabilities 10.1m
Non-Current Liabilities 15.5m
Long-Term Debt 5.2m
Other Non-Current Liabilities 10.2m
Efficiency

Free Cash Flow Analysis
Cumberland Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cumberland Pharmaceuticals Inc

Revenue
41.3m USD
Cost of Revenue
-6.4m USD
Gross Profit
34.9m USD
Operating Expenses
-38.1m USD
Operating Income
-3.3m USD
Other Expenses
-65.4k USD
Net Income
-3.3m USD
Fundamental Scores

CPIX Profitability Score
Profitability Due Diligence

Cumberland Pharmaceuticals Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROE is Increasing
Net Margin is Increasing
32/100
Profitability
Score

Cumberland Pharmaceuticals Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

CPIX Solvency Score
Solvency Due Diligence

Cumberland Pharmaceuticals Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
43/100
Solvency
Score

Cumberland Pharmaceuticals Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CPIX Price Targets Summary
Cumberland Pharmaceuticals Inc

There are no price targets for CPIX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cumberland Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CPIX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CPIX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CPIX stock?

The intrinsic value of one CPIX stock under the Base Case scenario is 1.77 USD.

Is CPIX stock undervalued or overvalued?

Compared to the current market price of 2.39 USD, Cumberland Pharmaceuticals Inc is Overvalued by 26%.

Back to Top